Adverse Drug Reactions Clinical Trial
— KAPHWDHRCOfficial title:
The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children: A Tertiary Center Experience
Verified date | September 2020 |
Source | Saglik Bilimleri Universitesi |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Adverse drug reactions are an important public health consern that affects physician prescriptions and practice. The responsibilities of healthcare professionals in monitoring, prevention, treatment and reporting of drug hypersensitivity reactions and drug allergies are essential for patient safety. Providing drug safety must be one of the main goals to be achieved for every member of our society. In our study, we planned to evaluate the knowledge, attitudes, and behaviors of healthcare workers in our country about drug hypersensitivity reactions in pediatric patients and to determine the risk factors that may affect them.
Status | Completed |
Enrollment | 354 |
Est. completion date | March 1, 2020 |
Est. primary completion date | February 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: The study included healthcare workers including medical doctors, nurses and dentists who perform interventions on children (0-18 years of age). Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
Turkey | Health Sciences University, Gülhane Training and Research Hospital, Gn. Dr. Tevfik Saglam Cd No:11 | Ankara | Etlik |
Lead Sponsor | Collaborator |
---|---|
Saglik Bilimleri Universitesi |
Turkey,
Dorji C, Tragulpiankit P, Riewpaiboon A, Tobgay T. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey. Drug Saf. 2016 Dec;39(12):1239-1250. — View Citation
Seid MA, Kasahun AE, Mante BM, Gebremariam SN. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia. Int J Clin Pharm. 2018 Aug;40(4):895-902. doi: 10.1007/s11096-0 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | we planned to evaluate the knowledge, attitudes, and behaviors of healthcare workers in our country about drug hypersensitivity reactions in pediatric patients | The knowledge level domain, consisted of 24 questions including mechanism of drug hypersensitivity reactions, clinical findings, diagnosis and treatment. The answer format was 3 options (yes/no /don't know). A triple variable scale was used for knowledge level (0 to 2: 0, false; 1, true; 2, do not know). The attitude domain consisted of 5 questions including the effect of DHRs on the patient's quality of life and advanced training and current diagnostic tests for the needs in this regard. A five-point Likert-type scale was used for the questions to determine the level of agreement or disagreement (1 to 5; 1 strongly disagree; 2, disagree; 3, uncertain; 4, agree; 5, strongly agree) The practice domain consisted of 9 questions including taking history and practice in drug allergy and advanced training in DHR. A Likert-type scale was used to determine the level of practices (1 - 5: 1, never; 2, very rarely; 3, sometimes; 4, often; 5, always). |
It is planned to fill the questionnaire in 2 hours. | |
Primary | we planned to evaluate the knowledge, attitudes, and behaviors of healthcare workers in our country about drug hypersensitivity reactions in pediatric patients | The knowledge level domain, consisted of 24 questions including mechanism of drug hypersensitivity reactions, clinical findings, diagnosis and treatment. The answer format was 3 options (yes/no /don't know). 2. The attitude domain consisted of 5 questions including the effect of DHRs on the patient's quality of life and advanced training and current diagnostic tests for the needs in this regard. A five-point Likert-type scale was used for the questions to determine the level of agreement or disagreement The practice domain consisted of 9 questions including taking history and practice in drug allergy and advanced training in DHR. A Likert-type scale was used to determine the level of practices |
It is planned to fill the questionnaire in 2 hours. | |
Secondary | to determine the risk factors that may affect the knowledge, attitudes, and behaviors of healthcare workers in our country about drug hypersensitivity reactions in pediatric patient | Participants'demographic questions regarding the age, gender, profession, duration in the profession, title and educational status of the participants may effect their surveys scores | It is planned to fill the questionnaire in 2 hours. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02239237 -
Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
|
||
Completed |
NCT02191358 -
YouScript IMPACT Registry
|
N/A | |
Recruiting |
NCT04547335 -
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
|
||
Recruiting |
NCT04743544 -
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
|
||
Completed |
NCT02378220 -
Pharmacogenetic Testing Among Home Health Patients
|
N/A | |
Completed |
NCT01467128 -
Adverse Drug Event Prevention Using Structured Pharmacist Review
|
Phase 4 | |
Completed |
NCT01354730 -
A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT04496024 -
Ofloxacin Concentration-toxicity Relationship in the Elderly
|
N/A | |
Completed |
NCT02097654 -
Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons
|
N/A | |
Completed |
NCT01764204 -
Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years
|
N/A | |
Completed |
NCT04279470 -
Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events
|
||
Recruiting |
NCT03640884 -
Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study
|
||
Completed |
NCT02122965 -
The Effect of Medication Review in High-risk Emergency Department Patients
|
N/A | |
Active, not recruiting |
NCT06456086 -
Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions
|
||
Completed |
NCT01058122 -
Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward
|
||
Recruiting |
NCT04479553 -
Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.
|